The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Optical Preclinical Imaging Market Research Report 2024
Synopsis
Surge in the number of preclinical studies aimed at developing various effective therapeutics for various diseases is increasing the adoption of optical preclinical imaging systems.
The global Optical Preclinical Imaging market was valued at US$ 433.2 million in 2023 and is anticipated to reach US$ 530.7 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The Optical Preclinical Imaging market represents a vital segment within the field of preclinical research, offering advanced imaging technologies and solutions for studying and visualizing biological processes and diseases in small animal models. Optical preclinical imaging encompasses various non-invasive imaging modalities such as bioluminescence imaging, fluorescence imaging, and multispectral imaging, which enable researchers to monitor and analyze the molecular and cellular events within living organisms. This market plays a crucial role in accelerating drug development, disease research, and the evaluation of potential therapeutic interventions, allowing scientists to gain valuable insights into the functioning of biological systems. The technology is widely utilized in pharmaceutical and biotechnology companies, academic research institutions, and contract research organizations to better understand diseases, test drug efficacy, and develop innovative therapies. Leading manufacturers and providers of optical preclinical imaging systems and software, including PerkinElmer, Bruker, and Caliper Life Sciences, offer cutting-edge solutions to support research efforts. As the demand for accurate, high-resolution, and non-invasive imaging in preclinical research continues to grow, the Optical Preclinical Imaging market remains at the forefront of scientific advancements and plays a pivotal role in driving breakthroughs in the field of life sciences and medicine.
This report aims to provide a comprehensive presentation of the global market for Optical Preclinical Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Optical Preclinical Imaging.
Report Scope
The Optical Preclinical Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Optical Preclinical Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Optical Preclinical Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bruker Corporation
Perkin Elmer, Inc.
MR Solutions
BioTek Instruments, Inc.
Milabs B.V.
Fujifilm Holdings Corporation
Magnetic Insight, Inc.
MBF Bioscience
Mediso
Caliper Life Sciences
Segment by Type
Devices
Consumables
Software
Segment by Application
Pharma and Biotech Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Optical Preclinical Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Surge in the number of preclinical studies aimed at developing various effective therapeutics for various diseases is increasing the adoption of optical preclinical imaging systems.
The global Optical Preclinical Imaging market was valued at US$ 433.2 million in 2023 and is anticipated to reach US$ 530.7 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The Optical Preclinical Imaging market represents a vital segment within the field of preclinical research, offering advanced imaging technologies and solutions for studying and visualizing biological processes and diseases in small animal models. Optical preclinical imaging encompasses various non-invasive imaging modalities such as bioluminescence imaging, fluorescence imaging, and multispectral imaging, which enable researchers to monitor and analyze the molecular and cellular events within living organisms. This market plays a crucial role in accelerating drug development, disease research, and the evaluation of potential therapeutic interventions, allowing scientists to gain valuable insights into the functioning of biological systems. The technology is widely utilized in pharmaceutical and biotechnology companies, academic research institutions, and contract research organizations to better understand diseases, test drug efficacy, and develop innovative therapies. Leading manufacturers and providers of optical preclinical imaging systems and software, including PerkinElmer, Bruker, and Caliper Life Sciences, offer cutting-edge solutions to support research efforts. As the demand for accurate, high-resolution, and non-invasive imaging in preclinical research continues to grow, the Optical Preclinical Imaging market remains at the forefront of scientific advancements and plays a pivotal role in driving breakthroughs in the field of life sciences and medicine.
This report aims to provide a comprehensive presentation of the global market for Optical Preclinical Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Optical Preclinical Imaging.
Report Scope
The Optical Preclinical Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Optical Preclinical Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Optical Preclinical Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bruker Corporation
Perkin Elmer, Inc.
MR Solutions
BioTek Instruments, Inc.
Milabs B.V.
Fujifilm Holdings Corporation
Magnetic Insight, Inc.
MBF Bioscience
Mediso
Caliper Life Sciences
Segment by Type
Devices
Consumables
Software
Segment by Application
Pharma and Biotech Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Optical Preclinical Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Optical Preclinical Imaging Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Devices
1.2.3 Consumables
1.2.4 Software
1.3 Market by Application
1.3.1 Global Optical Preclinical Imaging Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma and Biotech Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Optical Preclinical Imaging Market Perspective (2019-2030)
2.2 Optical Preclinical Imaging Growth Trends by Region
2.2.1 Global Optical Preclinical Imaging Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Optical Preclinical Imaging Historic Market Size by Region (2019-2024)
2.2.3 Optical Preclinical Imaging Forecasted Market Size by Region (2025-2030)
2.3 Optical Preclinical Imaging Market Dynamics
2.3.1 Optical Preclinical Imaging Industry Trends
2.3.2 Optical Preclinical Imaging Market Drivers
2.3.3 Optical Preclinical Imaging Market Challenges
2.3.4 Optical Preclinical Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Optical Preclinical Imaging Players by Revenue
3.1.1 Global Top Optical Preclinical Imaging Players by Revenue (2019-2024)
3.1.2 Global Optical Preclinical Imaging Revenue Market Share by Players (2019-2024)
3.2 Global Optical Preclinical Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Optical Preclinical Imaging Revenue
3.4 Global Optical Preclinical Imaging Market Concentration Ratio
3.4.1 Global Optical Preclinical Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Optical Preclinical Imaging Revenue in 2023
3.5 Optical Preclinical Imaging Key Players Head office and Area Served
3.6 Key Players Optical Preclinical Imaging Product Solution and Service
3.7 Date of Enter into Optical Preclinical Imaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Optical Preclinical Imaging Breakdown Data by Type
4.1 Global Optical Preclinical Imaging Historic Market Size by Type (2019-2024)
4.2 Global Optical Preclinical Imaging Forecasted Market Size by Type (2025-2030)
5 Optical Preclinical Imaging Breakdown Data by Application
5.1 Global Optical Preclinical Imaging Historic Market Size by Application (2019-2024)
5.2 Global Optical Preclinical Imaging Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Optical Preclinical Imaging Market Size (2019-2030)
6.2 North America Optical Preclinical Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Optical Preclinical Imaging Market Size by Country (2019-2024)
6.4 North America Optical Preclinical Imaging Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Optical Preclinical Imaging Market Size (2019-2030)
7.2 Europe Optical Preclinical Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Optical Preclinical Imaging Market Size by Country (2019-2024)
7.4 Europe Optical Preclinical Imaging Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Optical Preclinical Imaging Market Size (2019-2030)
8.2 Asia-Pacific Optical Preclinical Imaging Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Optical Preclinical Imaging Market Size by Region (2019-2024)
8.4 Asia-Pacific Optical Preclinical Imaging Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Optical Preclinical Imaging Market Size (2019-2030)
9.2 Latin America Optical Preclinical Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Optical Preclinical Imaging Market Size by Country (2019-2024)
9.4 Latin America Optical Preclinical Imaging Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Optical Preclinical Imaging Market Size (2019-2030)
10.2 Middle East & Africa Optical Preclinical Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Optical Preclinical Imaging Market Size by Country (2019-2024)
10.4 Middle East & Africa Optical Preclinical Imaging Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bruker Corporation
11.1.1 Bruker Corporation Company Detail
11.1.2 Bruker Corporation Business Overview
11.1.3 Bruker Corporation Optical Preclinical Imaging Introduction
11.1.4 Bruker Corporation Revenue in Optical Preclinical Imaging Business (2019-2024)
11.1.5 Bruker Corporation Recent Development
11.2 Perkin Elmer, Inc.
11.2.1 Perkin Elmer, Inc. Company Detail
11.2.2 Perkin Elmer, Inc. Business Overview
11.2.3 Perkin Elmer, Inc. Optical Preclinical Imaging Introduction
11.2.4 Perkin Elmer, Inc. Revenue in Optical Preclinical Imaging Business (2019-2024)
11.2.5 Perkin Elmer, Inc. Recent Development
11.3 MR Solutions
11.3.1 MR Solutions Company Detail
11.3.2 MR Solutions Business Overview
11.3.3 MR Solutions Optical Preclinical Imaging Introduction
11.3.4 MR Solutions Revenue in Optical Preclinical Imaging Business (2019-2024)
11.3.5 MR Solutions Recent Development
11.4 BioTek Instruments, Inc.
11.4.1 BioTek Instruments, Inc. Company Detail
11.4.2 BioTek Instruments, Inc. Business Overview
11.4.3 BioTek Instruments, Inc. Optical Preclinical Imaging Introduction
11.4.4 BioTek Instruments, Inc. Revenue in Optical Preclinical Imaging Business (2019-2024)
11.4.5 BioTek Instruments, Inc. Recent Development
11.5 Milabs B.V.
11.5.1 Milabs B.V. Company Detail
11.5.2 Milabs B.V. Business Overview
11.5.3 Milabs B.V. Optical Preclinical Imaging Introduction
11.5.4 Milabs B.V. Revenue in Optical Preclinical Imaging Business (2019-2024)
11.5.5 Milabs B.V. Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Company Detail
11.6.2 Fujifilm Holdings Corporation Business Overview
11.6.3 Fujifilm Holdings Corporation Optical Preclinical Imaging Introduction
11.6.4 Fujifilm Holdings Corporation Revenue in Optical Preclinical Imaging Business (2019-2024)
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 Magnetic Insight, Inc.
11.7.1 Magnetic Insight, Inc. Company Detail
11.7.2 Magnetic Insight, Inc. Business Overview
11.7.3 Magnetic Insight, Inc. Optical Preclinical Imaging Introduction
11.7.4 Magnetic Insight, Inc. Revenue in Optical Preclinical Imaging Business (2019-2024)
11.7.5 Magnetic Insight, Inc. Recent Development
11.8 MBF Bioscience
11.8.1 MBF Bioscience Company Detail
11.8.2 MBF Bioscience Business Overview
11.8.3 MBF Bioscience Optical Preclinical Imaging Introduction
11.8.4 MBF Bioscience Revenue in Optical Preclinical Imaging Business (2019-2024)
11.8.5 MBF Bioscience Recent Development
11.9 Mediso
11.9.1 Mediso Company Detail
11.9.2 Mediso Business Overview
11.9.3 Mediso Optical Preclinical Imaging Introduction
11.9.4 Mediso Revenue in Optical Preclinical Imaging Business (2019-2024)
11.9.5 Mediso Recent Development
11.10 Caliper Life Sciences
11.10.1 Caliper Life Sciences Company Detail
11.10.2 Caliper Life Sciences Business Overview
11.10.3 Caliper Life Sciences Optical Preclinical Imaging Introduction
11.10.4 Caliper Life Sciences Revenue in Optical Preclinical Imaging Business (2019-2024)
11.10.5 Caliper Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
